Related by context. All words. (Click for frequent words.) 77 Vaxfectin R adjuvant 71 Vaxfectin 70 TransVax TM 68 SynCon 68 TransVax tm 67 Vaxfectin TM 67 Vaxfectin TM adjuvant 67 SynCon ™ 67 Q#IR 67 pharmacodynamic markers 66 LEAPS TM 66 PER.C6 ® production 66 SynCon TM 66 AFFITOME R 66 DexaSite 65 Dyax phage display 65 eTag assays 65 Nanobody R 65 Potelligent Technology 65 HCV protease inhibitors 65 non nucleoside HCV 65 preclinical efficacy 65 trastuzumab emtansine T DM1 65 Adnectin 65 fusion enhancers 65 Thalomid ® 65 plasmid DNA vaccine 65 TransVax ™ 65 bazedoxifene conjugated estrogens 65 anti CD# antibodies 65 HDL Selective Delipidation 65 HuMax TAC 65 delafloxacin 65 LNP formulations 64 DOS# 64 OraTest R 64 pDNA vaccine 64 immune modulatory 64 XP #L 64 Multimeric 64 MoxDuo IR 64 Novavax VLP vaccine 64 PSMA ADC 64 RECOTHROM R 64 Oral NKTR 64 Exelixis compounds 64 Zysolin TM 64 biotherapeutic drugs 64 ENMD # 64 EHT AGN 64 DermaVir Patch 64 vidofludimus 64 rxRNA 64 Apoptone 64 Civacir 64 Vaxfectin adjuvant 64 phage display technology 64 Vascular Wrap TM 64 trastuzumab DM1 T DM1 63 successfully commercialize Iluvien 63 GRNVAC1 63 siRNAs targeting 63 REMINYL ® 63 LAB CGRP 63 Enhanze Technology 63 liposomal formulation 63 Fleximer R 63 MVA BN R 63 intradermal delivery 63 Japanese Encephalitis Vaccine 63 Nasdaq IDRA today 63 PEG SN# 63 BeneFIX 63 JAK inhibitor 63 XOMA 3AB 63 SYNERGY Stent 63 metaglidasen 63 torsemide ER 63 Tß4 63 GVAX ® 63 RIGScan CR 63 Fludara ® 63 deforolimus 63 Glufosfamide 63 molecular chaperone regulation 63 novel oral anticoagulant 63 Kosan dependence 63 evaluating tivozanib 63 DiLA2 63 confirmatory clinical 63 Thiovir 63 Symadex 63 candidate CRLX# 63 BioVant 63 Vaxfectin R formulated 63 mertansine 63 HGS# 63 OvaRex R 63 virosome technology 63 DXL TM 63 staphylococcal vaccine 63 MGN# 63 daptomycin 63 antiviral efficacy 63 trivalent seasonal influenza 63 IgG1 antibodies 63 antigen sparing 63 TÎ ² 4 63 YONDELIS 63 pharmacokinetic equivalence 63 torezolid phosphate 63 BACcel 63 Nanobody ® 63 TRX1 62 Dalbavancin 62 ARIKACE ™ 62 JAK inhibitors 62 proprietary PEGylation 62 Anticalins R 62 NovaBay Aganocide compounds 62 histone deacetylase HDAC 62 DPX Survivac 62 vivo potency 62 TLR antagonists 62 pharmacodynamic parameters 62 MenACWY CRM 62 Phase 1a clinical 62 SUTENT ® 62 ALN RSV program 62 MAGE A3 ASCI 62 mTOR inhibition 62 Alfacell proprietary ribonuclease 62 adenovirus serotype 62 PDE4 inhibitor 62 EndoTAG TM 62 patented Bioral 62 HGS ETR2 62 Onconase 62 TIMERx 62 CCX# 62 novel VDA molecule 62 oral salmon calcitonin 62 ZFN modified 62 dissolving microneedles 62 HepeX B 62 NovaDel oral spray 62 R roscovitine 62 Fibrin MB 62 VIRUSMAX TM 62 APTIMA HPV assay 62 CardioPET 62 Selective Electrochemical Tumor Ablation 62 indibulin 62 HCD# [002] 62 DepoVax 62 lipid nanoparticle 62 MoxDuo 62 Cumulase 62 therapeutic mAbs 62 Anticalin R 62 teriflunomide 62 pharmacodynamic properties 62 alvespimycin 62 preclinically 62 demonstrated clinically meaningful 62 ChronVac C R 62 synDNA TM 62 atacicept 62 optical biosensors 62 delipidation 62 personalized dendritic 62 Micromet BiTE 62 Presents Preclinical 62 Peptidomics 62 virosome 62 trivalent influenza vaccine 62 CA9 SCAN 62 synthetic retinoid 62 dacetuzumab 62 investigational humanized monoclonal antibody 62 NasdaqGM SPPI 61 Aganocide 61 HuCAL GOLD R 61 OncoVEX 61 CCR5 inhibitor 61 immunotherapeutic approaches 61 CRMD# 61 Anavex #-# 61 XP# XP# 61 Ramoplanin 61 epigenetic therapies 61 AzaSite Plus 61 Factor VIIa 61 Xanafide 61 encapsulates siRNAs 61 Zemplar Capsules 61 MALDI-TOF/TOF 61 Tarvacin TM 61 tranilast 61 DepoVax TM 61 demonstrated antitumor activity 61 Xcytrin R 61 tolevamer 61 Altastaph 61 Ketotransdel 61 novel emulsion formulation 61 PEGPH# 61 Anidulafungin 61 Allovectin 7 r 61 recombinant hepatitis B 61 research anddevelopment 61 THR beta agonist 61 introduced NEUGENE 61 CaPre TM 61 RECALL VAX 61 RE SURGE 61 maximally tolerated dose 61 therapeutic monoclonal antibodies 61 GIPET 61 intranasal delivery 61 TELINTRA 61 immune stimulatory 61 Fodosine 61 AeroLEF TM 61 ChronVac C 61 alemtuzumab MS 61 PORxin TM 61 synthetic siRNA 61 nucleotide analog 61 Cleviprex TM clevidipine 61 Vectibix panitumumab 61 pharmacodynamic PD 61 THALOMID 61 replicon 61 MVA BN ® 61 please visit www.advaxis.com 61 Nasulin ™ 61 NV1FGF 61 p# biomarker 61 Anticalin ® 61 humanized monoclonal antibodies 61 Aganocide ® 61 pharmacokinetic PK study 61 Octreolin 61 Panzem R NCD 61 Dynavax proprietary 61 MEK inhibitors 61 cMET 61 BioMatrix TM 61 HEPLISAV TM 61 antiangiogenic activity 61 Renin inhibitors 61 Activity Assay 61 ® bortezomib 61 anticancer activity 61 GVAX R 61 sirtuin modulators 61 Potelligent 61 SPRIX ® 61 Spiegelmer ® 61 combinability 61 Androxal TM 61 glycosylation profile 61 vitro ADME 61 ToleroMune 61 peptide conjugated 61 kidney urologic 61 CobaCyte 61 rhFVIIa 61 SIRT1 activators 61 Cethromycin 61 Genz # 61 Cerashield 61 CIP TRAMADOL ER 61 IgG1 61 INTERCEPT platelets 61 NXL# 61 Azedra 61 Nektar pulmonary 61 ChimeriVax JE 61 immunoregulation 61 efficacy tolerability 61 rhLF 61 website www.novavax.com 61 VIR# 61 paclitaxel Taxol ® 61 NASDAQ INGN 61 Valortim ® 61 potency selectivity 61 valent pneumococcal conjugate vaccine 61 Alequel TM 61 mda 7 61 oral prodrug 61 CysDisplay 60 PEGylated interferon 60 GERD migraine headaches 60 antisense inhibitors 60 Pimavanserin 60 thymidylate synthase TS 60 CG# [003] 60 PI3K/Akt pathway inhibitor 60 interferon gamma 1b 60 ATL# [002] 60 oral renin inhibitor 60 Vitaxin 60 viral kinetics 60 Urocidin TM 60 SMaRT ™ 60 Bavarian Nordic patented 60 RNAi therapeutic platform 60 HTS assay 60 CMV vaccine 60 Levulan ® PDT 60 eniluracil 60 XmAb# 60 Initiates Clinical 60 RECALL VAX TM 60 MoxDuo TM IR 60 CCR9 antagonist 60 Anticalins ® 60 Cytolin R 60 Alferon N 60 Technosphere ® 60 Recombinant Human 60 SinuNase ™ 60 virology immunology 60 BiTE 60 PD2i ® algorithm 60 Reports Preclinical Data 60 Surfaxin LS 60 coronary stent merged 60 Hyphanox 60 therapeutic monoclonal antibody 60 LibiGel ® 60 recombinant FVIII 60 metabolomic profiling 60 Fleximer 60 ZOLINZA 60 transfection reagents 60 biologic DMARD 60 Virulizin ® 60 Shigamabs 60 monoclonal antibody mAb 60 Nexavar sorafenib tablets 60 Immunotherapeutic 60 LPM TM 60 DermaVir 60 LHRH antagonists 60 OMNARIS Nasal Spray 60 R#/MEM 60 co receptor tropism 60 oral methylnaltrexone 60 Aloxi injection 60 Elvitegravir 60 intradermal injection 60 VDAs 60 JAK2 inhibitor 60 PREOS R 60 proteasome inhibitor 60 #ME# 60 Angiolix 60 Selexis 60 GeoVax AIDS vaccine 60 HTRF 60 tolerability profiles 60 Ceragenin ™ 60 PDE# inhibitors 60 PLAVIX ® 60 TOLAMBA 60 VeraTag 60 beta lactamase inhibitor 60 delivery polymer matrix 60 Guanilib 60 acetonide FA 60 ONCONASE R 60 DepoVax ™ vaccine 60 sargramostim 60 anti CD3 60 cathepsin K inhibitor 60 ZFP technology 60 Evoltra ® 60 liposome encapsulated 60 Duromist ™ 60 ONCASPAR 60 investigational hepatitis B 60 ETEC vaccine 60 personalized immunotherapy 60 evaluating satraplatin 60 CCR5 mAb 60 hyaluronidase enzyme 60 adenoviral vectors 60 Hsp# Inhibitor 60 AdVac ® 60 Shigamabs ® 60 TLR agonists 60 Biologic License Application BLA 60 Healive TM 60 DsiRNA 60 DAVANAT R exhibits 60 INCB# [001] 60 neuronal nicotinic receptor NNR 60 Phase Ib II 60 trodusquemine 60 ocular formulation 60 PRT# 60 phage display libraries 60 CLORETAZINE TM VNP#M 60 VersaFilm 60 Safinamide 60 humanized antibodies 60 protein tyrosine phosphatase 1B 60 carbohydrate compounds 60 visit www.genenews.com 60 Myocardial Perfusion Imaging 60 DAVANAT 60 MDx tests 60 nonclinical studies 60 GRN#L 60 Bioral Amphotericin B. 60 NurOwn 60 HuMax CD#b 60 SPRYCEL ® 60 Xelox 60 forodesine 60 NASDAQ FLML 60 Anticalins 60 ESBA# 60 HCV antiviral 60 biochemical profiling 60 splice variants 60 siRNA therapeutics 60 ganetespib 60 synthetic siRNAs 60 Nektar proprietary 60 Chrysalin 60 Pruvel 60 Dapagliflozin 60 Solulin 60 EXPAREL ™ 60 Combo Stent 60 biologic therapeutics 60 CANCIDAS 60 VivaGel TM 60 chimeric antibody 60 BRAF inhibitor 60 Presents Preclinical Data 60 AstraZeneca Toprol XL 60 histamine dihydrochloride 60 Synavive ™ 60 eliglustat tartrate 60 Panzem R 60 CERVARIX 60 subsidiaries visit http:/www.apricusbio.com 60 radezolid 60 alicaforsen enema 60 HepaGam B 60 recombinant interferon 60 ACUROX ® 60 pegylated IFN 59 ACTCellerate 59 visit www.targanta.com 59 AgaNase 59 technology visit http:/www.genmab.com 59 solithromycin 59 NEUGENE antisense 59 oral dnaJP1 59 Tekmira SNALP technology 59 sapacitabine CYC# 59 LEVAQUIN ® 59 selective orally bioavailable 59 NNRTI resistant virus 59 pharmacodynamic profile 59 systemic RNAi 59 EGFR HER2 59 MERLIN TIMI 59 velafermin 59 adipiplon 59 LB# [003] 59 Infinium assay 59 SUCCEED trial 59 P#X# antagonist 59 ulimorelin 59 Canvaxin TM 59 CRLX# 59 Initiates Enrollment 59 Solorel TM 59 inhibit metastasis 59 purinergic receptors P#X# 59 DiLA2 Platform 59 Pazopanib 59 MGd 59 HGS ETR1 mapatumumab 59 BHT DNA 59 XL# anticancer compounds 59 endosomal release 59 cisplatin gemcitabine 59 BioFocus DPI Galapagos 59 UPLYSO 59 antitumoral 59 Neuradiab 59 Telbivudine 59 topical hemostat 59 relapsed MM 59 Rigel R# 59 Tarceva TM 59 Fc fusion protein 59 HuCAL GOLD ® 59 Aeolus Pharmaceuticals Announces 59 InterfeRx 59 Prodarsan ® 59 lymphoid tumors 59 G#DT 59 Cardiotoxicity 59 Coronary stent 59 Zavesca r 59 FOLOTYN ® 59 BRIM3 59 bicifadine 59 CELVAPAN H#N# 59 TPI ASM8 59 ICA # 59 liposome formulations 59 Potelligent TM 59 #T# L1 59 OMNARIS HFA 59 ddRNAi 59 proprietary capillary aerosolization 59 clinical pharmacology studies 59 SNALP technology 59 proprietary VLP 59 VeraTag assays 59 wilate ® 59 HuCAL antibodies 59 JOULFERON 59 Sialic Switch technology 59 therapeutic peptide 59 VaxImmune 59 cGMP manufacture 59 VLP influenza 59 antiangiogenic agent 59 salmon calcitonin 59 Interferon beta 59 ESTRASORB 59 AERx ® 59 receptor inhibitor 59 biostatistical analysis 59 AAG geldanamycin analog 59 soft gelatin capsule 59 crizotinib PF # 59 elotuzumab 59 inhaled iloprost 59 Prestara 59 Vaccine Adjuvant 59 ALGRX 59 protein biochip 59 tezampanel NGX# 59 HepaMate 59 AZX# 59 platinum chemotherapeutic 59 CERVARIX R 59 Nasdaq PGNX today 59 oral talactoferrin 59 Pharmacokinetic parameters 59 immunotherapeutic vaccine 59 initiate multicenter 59 MoxDuo ® IR 59 DEEP AF 59 Immunomedics Announces 59 Afatinib 59 BARACLUDE R 59 Crucell PER.C6 59 Prodarsan R 59 vivo preclinical 59 Archexin 59 punctal plug 59 ZYBRESTAT fosbretabulin 59 EGS# 59 TBC# 59 peptide antigens 59 Trofex 59 ZFP TFs 59 Vidaza R 59 euro adhoc Intercell AG 59 OnDose 59 MET amplification 59 tolerability pharmacokinetics 59 panitumumab Vectibix 59 AtuRNAi 59 clevidipine 59 Captisol ® 59 pharmacokinetic characteristics 59 topoisomerase II inhibitor 59 Alvesco R 59 EndoTAG TM -1 59 HuLuc# 59 PENNVAX B 59 CYT# potent vascular disrupting 59 Loramyc R 59 custirsen 59 hemagglutination inhibition 59 Vancocin R 59 linear pharmacokinetics 59 Alkeran 59 tanespimycin 59 allosteric modulation 59 ruxolitinib 59 candidate TNFerade biologic 59 acyclovir Lauriad ® 59 situ gelling 59 SNT MC# 59 vivo efficacy 59 Fortical R 59 recombinant spider silk 59 Targretin capsules 59 novel peptide 59 antiangiogenic agents 59 LEP ETU 59 Drospirenone 59 Warfarin Coumadin 59 TOCOSOL Camptothecin 59 Poly ICR 59 programs visit http:/www.bionovo.com 59 Dabigatran etexilate 59 novel peptides 59 Nasdaq NPSP 59 pharmacokinetic properties 59 ReCyte 59 humanized monoclonal 59 NADiA 59 Crucell genetically engineered 59 recombinant antibodies 59 XTEN 59 Enhanze 59 HMG CoA reductase inhibitors 59 aplindore 59 pharmacokinetics pharmacodynamics 59 CONBRIZA 59 CTAP# Capsules 59 R sorafenib tablets 59 antitumor effect 59 EGFR antibodies 59 orally administered inhibitor 59 ThermoDox ® clinical 59 Protexia ® 59 PHX# 59 gemcitabine cisplatin 59 Androgel R 59 telomerase inhibitor 59 proprietary chemically modified 59 MAXY alpha 59 Carfilzomib 59 Ipsen Euronext IPN 59 microRNA profiling 59 acyclovir Lauriad R 59 TCAD therapy 59 DEB# 59 pharmacogenetic testing 59 orally bioavailable mimics 59 H#N# VLP vaccine 59 oral gallium 59 macrolide antibiotics 59 HEPLISAV ™ 59 rhMBL 59 hematological parameters 59 prostanoid 59 microtubule inhibitor 59 GTC recombinant human 59 enzyme immunoassay EIA 59 HDL Mimetic Peptide 59 AERx iDMS 59 Zoraxel TM 59 Dermylex TM 59 hepatitis B immunoglobulin 59 Captisol enabled 59 Progenta TM 59 Study #CL# 59 IRX 2 59 Vaxfectin TM formulated 59 DXL ™ 59 Shigamabs R 59 pharmacokinetic profiles 59 r hGH 59 iCell Cardiomyocytes 59 SNALP 59 oral deforolimus 59 CCR5 antagonist 59 POTELLIGENT R 59 BrachySil TM 59 idiotype protein 59 IMP# 59 mTOR kinase 59 Valdoxan 59 visit www.genmab.com 59 inhaled AAT 59 Transfection 59 Personalized Immunotherapy 59 tramiprosate Alzhemed TM 59 miRview meso 59 fosbretabulin 59 selective modulator 59 ActivX 58 calcitonin 58 antitumor efficacy 58 EXPAREL TM 58 DIFICID ™ 58 Rotarix R 58 OMP #M# 58 Tovaxin TM 58 Kahalalide F 58 relapsed MCL 58 PGL# 58 Pichia pastoris 58 Ganciclovir 58 developing TB4 58 histone deacetylase inhibitor 58 Orazol 58 menadione 58 JNJ Q2 58 Predictive medicine 58 SAR# [002] 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 toxicogenomic 58 influenza VLP vaccine 58 Triapine 58 proprietary BiTE ® 58 Capsulution 58 oral picoplatin 58 thalidomide Thalomid 58 favorable pharmacokinetic profile 58 Stimuvax R 58 dose proportionality 58 Phase IIB 58 antibiofilm 58 Novasome R 58 Xennex 58 Prednisporin 58 Chimigen TM 58 Sebivo 58 Humenza 58 bexarotene 58 Locked Nucleic Acid LNA 58 cleavable linker 58 Ventavis ® 58 Crucell PER.C6 ® 58 lumiliximab 58 Hemopurifier ® 58 Staphylococcus aureus Polysaccharide Conjugate 58 PORxin TM platforms 58 bioprocesses 58 endothelin antagonist 58 RenalGuard System TM 58 bioinformatic approaches 58 ZFP Therapeutics 58 multicenter Phase II 58 MChip 58 Omacor ® 58 intracellular uptake 58 Hectorol R 58 immunological responses 58 ganaxolone 58 antiapoptotic 58 reslizumab 58 cyclophilin inhibitor 58 Tekturna HCT 58 Granulocyte Colony Stimulating Factor 58 ceftazidime 58 xMAP technology 58 Neovasc Reducer 58 COPEGUS therapy 58 RiVax ™ 58 JVRS 58 Spiegelmers 58 celgosivir 58 serogroup B 58 quantitative PCR qPCR 58 Dual Opioid TM 58 UsiRNAs 58 SIMCOR ® 58 volociximab 58 includes TOLAMBA TM 58 hydrophobic docetaxel prodrug nanoparticle 58 barrier gauze dressings 58 CorVue ™ 58 nitric oxide donating prostaglandin 58 ON #.Na 58 Systemic Delivery 58 plasmid DNA pDNA 58 Specialty Enzymes 58 PrevOnco ™ 58 NASDAQ DYAX 58 TLR9 agonists 58 NEUMUNE 58 Cardio Vascu Grow 58 OncoVEX GM CSF 58 indications contraindications 58 AEGR 58 recombinant albumin 58 ATIR ™ 58 Epothilones 58 novel histone deacetylase 58 eligen 58 Transfection Reagent 58 resorbable biomaterials 58 hemagglutination inhibition HAI 58 hematological tumors 58 Recombumin 58 elvitegravir 58 Xeloda ® 58 Inovio electroporation 58 Therapeutic Competitors Companies 58 IMA# 58 Prolexys 58 targeted antifolate 58 HuCNS SC ® 58 STRIDE PD 58 UltiMAb 58 Cx# [002] 58 NN# [001] 58 selective estrogen receptor modulator 58 tubulin inhibitor 58 TAT# 58 CTA# 58 Preclinical studies suggest 58 RapidResponse TM DNA 58 Platinol ® cisplatin 58 anticancer therapeutics 58 MYDICAR ® 58 ACAPODENE TM 58 ospemifene 58 Phase lll 58 genotypic resistance 58 RECOTHROM ® 58 peptibody 58 Soliris eculizumab 58 oral ridaforolimus 58 clade B 58 succinic 58 EDEMA3 58 Cyclosert 58 EDEMA3 trial 58 ANAVEX #-# [001] 58 Antigenics QS 58 micafungin 58 antitumour 58 CIMZIA ™ 58 plasma pharmacokinetics 58 omecamtiv mecarbil 58 defensin mimetic antibiotic 58 2A receptor agonist 58 Pain Neutralizer holds 58 Tumor Response 58 OvaRex ® MAb 58 vitro cytotoxicity 58 subunit vaccines 58 Flow cytometry 58 OVA1 ® 58 Bicifadine 58 Proquin XR 58 nitazoxanide 58 lipidoid 58 hypoxia selective 58 Transdermal Delivery 58 SCH # 58 HspE7 58 NASDAQ ABII 58 Allovectin 7 ® 58 Crofelemer budesonide foam 58 systemic immunosuppressive drugs 58 Inovio DNA 58 XL# SAR# 58 Proellex TM 58 EP #R 58 Ecallantide 58 Intravail R 58 Maxy G# 58 Azedra ™ 58 BiTE R 58 Neugene 58 topical dermatology 58 InterfeRx TM 58 transcutaneous immunization TCI 58 Atripla combines 58 Somatuline R Depot 58 NSABP C 58 rThrombin 58 ERYtech Pharma 58 Virosome Biologicals 58 hepatitis B immune globulin 58 LEVADEX ™ 58 midstage clinical 58 CINQUIL 58 NEUGENE 58 MAXY VII 58 fibrotic disease 58 QTinno TM 58 ICH guidelines 58 cMET inhibitor 58 DuraSite ® 58 Hepatitis C Virus HCV 58 Celadrin R 58 anionic backbone 58 mechanistic studies 58 LT NS# 58 telomerase therapeutic 58 ARB telmisartan 58 prospectively stratified 58 homocysteine assay 58 MNTX 58 Vaxfectin formulated 58 lamivudine zidovudine 58 Human cl 58 orally inhaled migraine 58 ongoing Phase IIIb 58 VivaGel ™ 58 BioSilicon 58 topical gel containing 58 phase IIb trial 58 Thorough QT 58 Abstract Accepted 58 recombinant biopharmaceutical 58 octreotide acetate 58 CIPN 58 GVAX cancer 58 S1P antibody 58 Alnylam #x# 58 NADiA R 58 anti CD3 antibody 58 desvenlafaxine succinate 58 depsipeptide 58 LUNESTA TM 58 MUSE ® 58 TLR9 agonist 58 DermaPrep 58 Gammagard Liquid 58 Pertuzumab 58 genomic biomarker 58 NeutroSpec TM 58 microdroplet based 58 Phase #b/#a 58 HuMax EGFr 58 mTOR inhibitors 58 Solazed 58 Initiates Phase II 58 VIDAZA ® 58 NeuroVax TM 58 NexACT ® 58 Achieves Primary Endpoint 58 TRACON Pharmaceuticals 58 physiologically relevant 58 Vilazodone 58 Gord Froehlich President 58 LC#m# 58 Dextofisopam 58 MEND CABG II 58 RainStorm 58 Contramid R 58 Deforolimus 58 cidofovir 58 Completes Patient Enrollment 58 ADAMTS# 58 immunoregulatory 58 EOquin TM 58 OTCBB UGNE http:/www.unigene.com 58 faropenem 58 conserved antigens NP 58 S/GSK# 58 immunomodulation 58 pharmacodynamic profiles 58 APOPTONE 58 NP2 Enkephalin 58 Illumina Solexa 58 IG HCR ;) CO 58 rxRNA ™ compounds 58 Ampakine 58 novel L DOS# 58 silico prediction 58 Altrazeal R 58 DASISION 58 ritonavir boosted danoprevir 58 FOLFOX6 chemotherapy regimen 58 world safest multivalent 58 ACTOS ® 58 Cethrin R 58 RE COVER 58 sitaxsentan 58 antiplatelet therapies 58 phase IIb clinical 58 regenerative stem cell 58 ZADAXIN ® 58 TOCOSOL Paclitaxel 58 Vernakalant 58 Gilead Viread 58 Alequel ™ 58 Elan NanoCrystal 58 Carigent 58 trastuzumab DM1 58 Crop BioScience 58 TriRima 58 Pitavastatin